Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Titel:
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Auteur:
Pose, Elisa Napoleone, Laura Amin, Ahmed Campion, Daniela Jimenez, César Piano, Salvatore Roux, Olivier Uschner, Frank Erhard de Wit, Koos Zaccherini, Giacomo Alessandria, Carlo Angeli, Paolo Bernardi, Mauro Beuers, Ulrich Caraceni, Paolo Durand, François Mookerjee, Rajeshwar P Trebicka, Jonel Vargas, Victor Andrade, Raúl J Carol, Marta Pich, Judit Ferrero, Juan Domenech, Gema Llopis, Marta Torres, Ferran Kamath, Patrick S Abraldes, Juan G Solà, Elsa Ginès, Pere